- Reuters•18 minutes ago
Mylan NV said on Wednesday its application to market a generic copy of GlaxoSmithKline Plc's blockbuster inhaled lung drug Advair was rejected by the U.S. Food and Drug Administration. The drugmaker did ...
- Investopedia•2 hours ago
Glaxo is relieved after the FDA apparently did not approve Mylan's generic version of GSK's Advair.
- Market Realist•3 hours ago
HIV products reported growth of 37% to ~3.6 million pounds in 2016 compared to 2015.
GSK : Summary for GlaxoSmithKline PLC Common Stoc - Yahoo Finance
GlaxoSmithKline plc (GSK)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||42.16 - 42.76|
|52 Week Range||37.20 - 45.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||93.99|
|Dividend & Yield||2.00 (4.70%)|
|1y Target Est||N/A|